ArticleScientific reports2026
Longitudinal evaluation of the psychometric stability of the somatic symptom scale-8 (SSS-8) in a large German general population sample.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Somatic Symptom Scale (SSS-8) is a brief 8-item tool for screening common somatic symptoms. This study is the first to examine its temporal invariance and stability across three COVID-19 pandemic time points, while also analyzing changes in SSS-8 scores in the general population and across groups (sex, age, relationship status, poverty status), and testing temporal stability and measurement invariance. Longitudinal data from three pandemic time points in a large population-based sample were used. Temporal stability was assessed using Pearson correlations, and confirmatory factor analysis with measurement invariance testing examined factor validity and temporal invariance. The SSS-8 decreased from the first to the second measurement and subsequently increased between the second and third time points. The scale demonstrated good internal consistency (α ≥ 0.78, ω ≥ 0.82) and temporal stability, with test-retest coefficients ranging from 0.696 to 0.752. Across groups, female sex, age under 60, being not at-risk-of-poverty, and no necessary medical visits during the pandemic were consistently associated with lower test-retest coefficients than their counterparts. Confirmatory factor analysis showed good model fit (CFI = 0.985, TLI = 0.975, RMSEA = 0.040, SRMR = 0.035), and measurement invariance across time points was established (ΔCFI < 0.010). Consistent with other studies, somatic symptom burdening initially decreased and subsequently increased at the third measurement time point. The increase is discussed in the context of the pandemic and the serious political crisis in 2022. Overall, the scale demonstrated good psychometric properties including sensitivity to major crises of life conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.